Increased Mortality Fuels Early Concern Over ESA Stroke Study

A greater mortality in patients treated with epoetin alfa in a German study evaluating the drug's potential neuroprotective effects in stroke patients is the subject of an ongoing safety review at the Food and Drug Administration.